Union Health Ministry may postpone NEET-MDS exam by 4-6 weeks

NEET-MDS examination 2022 may be postponed by four to six weeks and the date of completion of a compulsory rotating internship for eligibility for admission to MDS courses may be fixed at July 31, 2022 instead of March 31, 2022, said the Union Ministry of Health and Family Welfare on Thursday.

“It is informed that the matter has been examined in this Ministry and in order to bring parity between the NEET-MDS 2022 and NEET-PG 2022 examination, it has been decided by the Competent Authority that the date for the conduct of NEET-MDS examination 2022 may be postponed by 4-6 weeks and preferably around the same date as that for NEET-PG 2022,” reads the Union Health Ministry’s letter.

“It has also been decided by the Competent Authority that the date of completion of a compulsory rotating internship for eligibility for admission to MDS courses may be fixed at July 31 2022 instead of March 31 2022,” said the Ministry of Health and Family Welfare.

  • Related Posts

    Apollo Navi Mumbai launches geriatric oncology clinic

    With a dedicated Geriatric Oncology Clinic, Apollo Hospitals Navi Mumbai brings specialised geriatric cancer care to the private healthcare setting in Navi Mumbai. With the launch of the Geriatric Oncology…

    Maharashtra FDA cancels licences of 62 pharma units, 141 chemist shops

    Mumbai: The Food and Drug Administration (FDA) has cracked down on medical stores violating drug-sale rules, suspending 599 licences and cancelling another 141 after inspecting 2,295 retail establishments across the…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Apollo Navi Mumbai launches geriatric oncology clinic

    Apollo Navi Mumbai launches geriatric oncology clinic

    Maharashtra FDA cancels licences of 62 pharma units, 141 chemist shops

    Maharashtra FDA cancels licences of 62 pharma units, 141 chemist shops

    Himachal DCA honoured with ‘Regulatory Excellence Award’ at iPHEX 2026

    Himachal DCA honoured with ‘Regulatory Excellence Award’ at iPHEX 2026

    Baddi pharma firm loses licence after 1,200-kg tapentadol haul

    Baddi pharma firm loses licence after 1,200-kg tapentadol haul

    US FDA takes steps to maintain newborn access to life-saving starter nutrition products

    US FDA takes steps to maintain newborn access to life-saving starter nutrition products

    Mankind Pharma launches campaign to inspire 1 crore Indians to pledge for organ donation